How is the Palisade Bio Inc today?

The Palisade Bio Inc today is trading in the green, up by 5.26% at 0.80.

What is Palisade Bio Inc Annual Net Profit?

Palisade Bio Inc Annual Net Profit fell 17.38% in the last year to $14.44 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is Palisade Bio Inc Price to Earning Ratio?

Palisade Bio Inc Price to Earning Ratio is -0.3, which is negative.

What is Palisade Bio Inc Stock Price?

Palisade Bio Inc Stock Price fell 84.5% and underperformed its sector by 96.38% in the past year.

What is Palisade Bio Inc Quarterly Net profit?

Palisade Bio Inc Quarterly Net profit rose 36.77% YoY to $2.23 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is Palisade Bio Inc Debt to Equity Ratio?

Palisade Bio Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Palisade Bio Inc Return on Equity(ROE)?

Palisade Bio Inc Return on Equity(ROE) for the last financial year was -153.59%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Palisade Bio Inc Mutual Fund Holding?

Palisade Bio Inc Mutual Fund Holding increased by 0.11% in the last quarter to 1.68.

What is Palisade Bio Inc Interest Coverage Ratio?

Palisade Bio Inc Interest Coverage Ratio is -1202.17, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Palisade Bio Inc Institutional Holding?

Palisade Bio Inc Institutional Holding increased by 1.08% in the last quarter to 6.17.

Palisade Bio Inc XNAS: PALI

Palisade Bio Inc Live Share Price Today, Share Analysis and Chart

Name: Palisade Bio Inc: Is Infosys Ltd. worth buying?
Item: Palisade Bio Inc
Rating: 0.97341675
Author: Trendlyne DVM scores

about

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and i...

0.80 0.04 (5.26%)

85.51% Fall from 52W High

69,501 XNAS Volume

XNAS 23 May, 2025 12:10 PM (EDT)

Not Eligible

-

Expensive Valuation

14.2 / 100

Technically Bearish

24.8 / 100

18

1Yr Price target upside is 2150%

3 analysts

Palisade Bio Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Palisade Bio Inc FAQ

How is Palisade Bio Inc today?

Palisade Bio Inc today is trading in the green, and is up by 5.26% at 0.80.

How has Palisade Bio Inc performed historically?

Palisade Bio Inc is currently trading up 5.26% on an intraday basis. In the past week the stock rose 17.65%. stock has been down -14.89% in the past quarter and fell -84.50% in the past year. You can view this in the overview section.